Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
advancing cell-specific drug delivery approaches. The project is funded by an ERC-2022-Consolidator Grant, entitled “Artifying fibroblasts: Perturbation modelling in the lung tumor phase space to rewire
-
applications in astrophysics and/or Earth observation, with particular emphasis on the synthesis, interpretation, and modeling of large datasets. Where to apply Website https://apella.minedu.gov.gr/en/node/5999
-
, membranes and advanced electrochemical systems. Collaborate with AI and computational science teams to accelerate discovery using machine learning, large language models (LLMs), and large quantitative models
-
contribute to the theoretical and observational study of milli-lens systems, with particular emphasis on testing different lens models and approximations within several dark matter theoretical frameworks
-
integrated modelling. The key role of the candidate focusses on investigating and implementing neuromorphic algorithms algorithms to dedicated photonic reconfigurable systems. Job is in the context of EU
-
of neurotrophin ligands with desired pharmacological properties and evaluates them in neural cultures (primary, human iPS-induced), and mouse models of neurodegeneration and CNS injury. The “Biomaterials and
-
services into the European Collaborative Cloud for Cultural Heritage (ECCCH). The focus will be on data modelling, analysis and visualization, exploring data acquired using imaging and spectroscopic
-
software applications for data modelling, analysis, and visualisation. These applications will explore data acquired using imaging and spectroscopic techniques to provide information on the nature and light
-
Description The Arthropod Disease Vector Biology lab (https://www.imbb.forth.gr/en/research ), headed by Dr. Michail Kotsyfakis, invites applications for one research assistant position to work on the newly
-
animal models, as well as new biomarkers for the neurodegenerative diseases Alzheimer's and Parkinson's & Development of innovative preclinical therapeutic interventions against the early onset